SREBF1 is a transcriptional factor related to lipid synthesis, regulating the homeostasis of cholesterol and fatty acids [60], and it was identified as a potential tool for treating obesity-related metabolic syndrome since SREBF1 inhibition can suppress lipogenesis. This evidence concerns the gene SREBF1 and obesity due to melanocortin 4 receptor deficiency.